SMAG is a rare pure-play on the mobile communications infrastructure behind the digital battlefield.
Carlsquare Equity Research har publicerat en initial kommentar på kv2-rapporten.
Catella's second quarter was a stable print against a low bar.
Flughafen Wien delivered better-than-expected Q2 results and raised its 2026 guidance, confirming th...
Agtira levererade sitt starkaste kvartal hittills, med en omsättningsökning på 118 procent och posit...
* Q2 EBIT of SEK 8m, vs. ABGSC of SEK 26m and cons.
SUS delivered a strong Q2, beating expectations on both sales and EBIT.
Vi inleder bevakning på Argo Defence, en snabbväxande och lönsam försvarskoncern med verksamhet inom...
Cantargia completed the rights issue in Q2, bringing in SEK75m before costs and entering into a loan...
Xplora reported soft revenue and gross profit for the historically seasonally neutral Q2, 9% and 5% ...
Redeye updates its estimates and valuation following Collaxio’s Q2 2026 report.
Xplora reported senior revenue down 20% at NOK198.4m and deferred the Doro Connect retail rollout fo...
Redeye updates its estimates and valuation after Boreo’s Q2 2026 report.
Today, 19 August, Alexander Hagemann, CEO of Cicor presented at Nordea’s Small and Mid Cap Days.
The scenario we outlined in our Q2 update has largely materialised, with Xspray reporting a Dasynoc ...
Redeye provides a research update following the Q2 report published by Cinclus earlier today.
Redeye views the term sheet and potential for a commercial license agreement with Hipolabor as a log...
Redeye provides its initial take on Collaxio’s Q2 2026 report, which featured a c13% q/q increase in...
SynAct Pharma has signed a term sheet with established Brazilian pharmaceutical company Hipolabor fo...
* Q2 EBITDA 13% below cons on lower senior device sales * Doro Connect first retail pilot complete, ...